The U.S. Food and Drug Administration classified the recall of the PC unit of a certain model of the CareFusion Alaris Infusion pump as Class I on Wednesday. The Alaris PC unit model 8015 has a component that is causing error messages like “System Error” or “Missing Battery Error” at startup. On June 27, CareFusion (NYSE:CFN) […]
Medical device startup NeuroWave Systems Inc. has reached a deal in which CareFusion (NYSE: CFN) will distribute NeuroWave's brain-activity monitoring system in Germany and Scandinavia. It's an important step for Cleveland Heights, Ohio-based NeuroWave, which in June received European regulatory clearance to begin selling its NeuroSense brain monitor for assessing anesthesia levels.
By reducing administrative burden and redesigning workflows around human needs, it creates space for what matters most: connection between clinicians and patients.
A federal judge in California dealt a setback to CareFusion Corp. (NYSE:CFN) in its anti-trust and patent infringement lawsuit against Medtronic Inc. (NYSE:MDT), tossing the anti-trust claims but giving CareFusion an out. Judge Lucy Koh of the U.S. District Court for Northern California ruled that CareFusion failed to prove that Medtronic sought to illegally dominate […]
Pharmaceutical and medical products supplier Cardinal Health Inc. has sold its remaining stake in spinoff medical technology company CareFusion for $706 million.
About 800,000 American per year are medical tourists--that is they leave the cozy confines of the good ol' US of A to seek medical treatment in cheaper locales. But where's the intrepid medical tourist to go, and for what procedures?
CareFusion Corp. (NYSE:CFN) posted bottom-line declines for both the fourth quarter and its first year as a public company, prompting the medical device maker to slash its workforce by 4.7 percent despite positive top-line growth. San Diego-based CareFusion reported profits of $52 million, or 23 cents per diluted share, on sales of $1.04 billion during […]
The U.S. Food & Drug Administration said it is requiring nine medical device companies to conduct postmarket analysis on a connection between needless connectors and higher rates of blood stream infections. In a notice posted on the Centers for Devices and Radiological Health web site, officials said that the agency is “aware of information that […]
Medical technology company CareFusion Corp.–spun out by Ohio’s Cardinal Health late last summer–has sued Medtronic Inc., accusing the Fridley, Minn., medical device giant of monopolistic and predatory practices in the market for products to treat compression fractures of spinal vertebrae. “CareFusion has been the victim of a scheme by the defendants to keep competitors out […]
Boston Scientific estimated this issue, plus an advisory related to a small number of defibrillator issues that sparked product changes, could hurt this year's heart-rhythm business sales by up to $100 million. The whole business, which includes pacemakers and defibrillators, posted 2009 sales of $2.56 billion.
Strong fourth-quarter sales for surgical-robot maker Intuitive Surgical Inc. and sales improvements for General Electric Co.'s Healthcare unit on Friday suggest U.S. hospitals may be ready to spend again on expensive capital equipment.
Discover the top AI-powered EAP providers for 2026. Compare platforms like Kyan Health and Spring Health on triage speed, global reach, and clinical quality to transform workforce wellbeing.
The University of Cincinnati College of Medicine has launched an early stage cancer drug development program and phase-1 clinical trials unit for patients who have solid tumors that have resisted cancer therapies.
Thousands of Ohioans could lost their homes and possibly even their health and lives right now, not because of the loss of jobs but rather state budget cuts to mental health services, according to WKSU News.
Danielle Everman had never heard of pelvic prolapse until she started the Medical Device Innovation and Entrepreneurship Program at the University of Cincinnati.
Cardinal Health is thinking about selling some CareFusion stock, sending the California spinoff's stock down on Wednesday.
Cardinal posted a $38.2 million loss, or 11 cents per share, during this fiscal first quarter -- compared to a profit of $249.1 million, or 69 cents per share, compared to last year at this time. Cardinal took a 71 cent per-share charge as a result of the spin-off.